130 related articles for article (PubMed ID: 23102541)
1. [National prostate cancer registry 2010 in Spain].
Cózar JM; Miñana B; Gómez-Veiga F; Rodríguez-Antolín A; Villavicencio H; Cantalapiedra A; Pedrosa E
Actas Urol Esp; 2013 Jan; 37(1):12-9. PubMed ID: 23102541
[TBL] [Abstract][Full Text] [Related]
2. Prostate cancer incidence and newly diagnosed patient profile in Spain in 2010.
Cózar JM; Miñana B; Gómez-Veiga F; Rodríguez-Antolín A; Villavicencio H; ; Cantalapiedra A; Pedrosa E
BJU Int; 2012 Dec; 110(11 Pt B):E701-6. PubMed ID: 22989066
[TBL] [Abstract][Full Text] [Related]
3. [Epidemiological trends in prostate cancer over the last years].
Luján Galán M; Páez Borda A; Chiva Robles V; Santonja Garriga C; Romero Cajigal I; Berenguer Sánchez A
Arch Esp Urol; 2004 Oct; 57(8):817-25. PubMed ID: 15560270
[TBL] [Abstract][Full Text] [Related]
4. Comparative analysis of the incidence of bladder cancer in the communities of Andalusia, Catalonia and Madrid in 2011.
Cózar JM; Miñana B; Palou-Redorta J; Medina RA; de la Rosa-Kehrmann F; Lozano-Palacio F; Ribal-Caparrós MJ; Hernández-Fernández C; Castiñeiras-Fernández JJ; Requena MJ; Moreno-Sierra J; Carballido-Rodríguez J; Baena-González V
Actas Urol Esp; 2015 Sep; 39(7):420-8. PubMed ID: 25554606
[TBL] [Abstract][Full Text] [Related]
5. An incidence model of the cost of advanced prostate cancer in Spain.
Hart WM; Nazir J; Baskin-Bey E
J Med Econ; 2014 Feb; 17(2):125-31. PubMed ID: 24350997
[TBL] [Abstract][Full Text] [Related]
6. [Epidemiologic indicators of adenocarcinoma of the prostate. Results on 436 patients].
Arrizabalaga Moreno M; García González JI; Diez Rodríguez JM; Esteban Artiaga R; Castro Pita M; Navarro Sebastian J; Mora Durbán M; Paniagua Andrés P
Actas Urol Esp; 1997 Oct; 21(9):852-61. PubMed ID: 9471868
[TBL] [Abstract][Full Text] [Related]
7. Clinical and histopathological characteristics of familial prostate cancer in Finland.
Pakkanen S; Kujala PM; Ha N; Matikainen MP; Schleutker J; Tammela TL
BJU Int; 2012 Feb; 109(4):557-63. PubMed ID: 21507186
[TBL] [Abstract][Full Text] [Related]
8. Prostate cancer diagnosed after prostate-specific antigen testing of men without clinical signs of the disease: a population-based study from the National Prostate Cancer Register of Sweden.
Bratt O; Berglund A; Adolfsson J; Johansson JE; Törnblom M; Stattin P;
Scand J Urol Nephrol; 2010 Dec; 44(6):384-90. PubMed ID: 20624113
[TBL] [Abstract][Full Text] [Related]
9. Use of β-blockers is associated with prostate cancer-specific survival in prostate cancer patients on androgen deprivation therapy.
Grytli HH; Fagerland MW; Fosså SD; Taskén KA; Håheim LL
Prostate; 2013 Feb; 73(3):250-60. PubMed ID: 22821802
[TBL] [Abstract][Full Text] [Related]
10. Characteristics of cases with unknown stage prostate cancer in a population-based cancer registry.
Luo Q; Yu XQ; Cooke-Yarborough C; Smith DP; O'Connell DL
Cancer Epidemiol; 2013 Dec; 37(6):813-9. PubMed ID: 24103424
[TBL] [Abstract][Full Text] [Related]
11. Prostate cancer in Denmark 1978-2009--trends in incidence and mortality.
Outzen M; Brasso K; Martinussen N; Christensen J; Tjønneland A; Friis S; Olsen A
Acta Oncol; 2013 May; 52(4):831-6. PubMed ID: 22809166
[TBL] [Abstract][Full Text] [Related]
12. Clinical characteristics and primary treatment of prostate cancer in Sweden between 1996 and 2005.
Adolfsson J; Garmo H; Varenhorst E; Ahlgren G; Ahlstrand C; Andrén O; Bill-Axelson A; Bratt O; Damber JE; Hellström K; Hellström M; Holmberg E; Holmberg L; Hugosson J; Johansson JE; Petterson B; Törnblom M; Widmark A; Stattin P
Scand J Urol Nephrol; 2007; 41(6):456-77. PubMed ID: 17934985
[TBL] [Abstract][Full Text] [Related]
13. [The prostate cancer in the community of Madrid in 2000 I.- Incidence].
Herranz Amo F; Arias Funez F; Arrizabalaga Moreno M; Calahorra Fernández FJ; Carballido Rodríguez J; Diz Rodríguez R; Herrero Payo JA; Llorente Abarca C; Martín Martínez JC; Martínez-Piñeiro Lorenzo L; Mínguez Martínez R; Moreno Sierra J; Rodríguez Antolín A; Tamayo Ruiz JC; Turo Antona J
Actas Urol Esp; 2003 May; 27(5):323-34. PubMed ID: 12891909
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology of hip fracture in the elderly in Spain.
Alvarez-Nebreda ML; Jiménez AB; Rodríguez P; Serra JA
Bone; 2008 Feb; 42(2):278-85. PubMed ID: 18037366
[TBL] [Abstract][Full Text] [Related]
15. Detection rates and biologic significance of prostate cancer with PSA less than 4.0 ng/mL: observation and clinical implications from Tyrol screening project.
Pelzer AE; Tewari A; Bektic J; Berger AP; Frauscher F; Bartsch G; Horninger W
Urology; 2005 Nov; 66(5):1029-33. PubMed ID: 16286118
[TBL] [Abstract][Full Text] [Related]
16. Population-based analysis of prostate-specific antigen (PSA) screening in younger men (<55 years) in Australia.
Ranasinghe WK; Kim SP; Lawrentschuk N; Sengupta S; Hounsome L; Barber J; Jones R; Davis P; Bolton D; Persad R
BJU Int; 2014 Jan; 113(1):77-83. PubMed ID: 24053128
[TBL] [Abstract][Full Text] [Related]
17. Bladder cancer in Spain 2011: population based study.
Miñana B; Cózar JM; Palou J; Unda Urzaiz M; Medina-Lopez RA; Subirá Ríos J; de la Rosa-Kehrmann F; Chantada-Abal V; Lozano F; Ribal MJ; Rodríguez Fernández E; Castiñeiras Fernández J; Concepción Masip T; Requena-Tapia MJ; Moreno-Sierra J; Hevia M; Gómez Rodríguez A; Martínez-Ballesteros C; Ramos M; Amón Sesmero JH; Pizá Reus P; Bohorquez Barrientos A; Rioja Sanz C; Gomez-Pascual JA; Hidalgo Zabala E; Parra Escobar JL; Serrano O
J Urol; 2014 Feb; 191(2):323-8. PubMed ID: 23994371
[TBL] [Abstract][Full Text] [Related]
18. Adenocarcinoma of the prostate in Iceland: a population-based study of stage, Gleason grade, treatment and long-term survival in males diagnosed between 1983 and 1987.
Jonsson E; Sigbjarnarson HP; Tomasson J; Benediktsdottir KR; Tryggvadottir L; Hrafnkelsson J; Olafsdottir EJ; Tulinius H; Jonasson JG
Scand J Urol Nephrol; 2006; 40(4):265-71. PubMed ID: 16916765
[TBL] [Abstract][Full Text] [Related]
19. Population-based incidence of basal cell carcinoma in a Spanish Mediterranean area.
Bielsa I; Soria X; Esteve M; Ferrándiz C;
Br J Dermatol; 2009 Dec; 161(6):1341-6. PubMed ID: 19796178
[TBL] [Abstract][Full Text] [Related]
20. A population-based study of the influence of socioeconomic status on prostate cancer diagnosis in Taiwan.
Wu CC; Lin CH; Chiang HS; Tang MJ
Int J Equity Health; 2018 Jun; 17(1):79. PubMed ID: 29903010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
